Literature DB >> 23469757

Folate conjugation to polymeric micelles via boronic acid ester to deliver platinum drugs to ovarian cancer cell lines.

Wei Scarano1, Hien T T Duong, Hongxu Lu, Paul L De Souza, Martina H Stenzel.   

Abstract

In this study, a novel technique was used for the reversible attachment of folic acid on the surface of polymeric micelles for a tumor-specific drug delivery system. The reversible conjugation is based on the interaction between phenylboronic acid (PBA) and dopamine to form a borate ester. The conjugation is fast and efficient and in vitro experiments via confocal fluorescent microscopy show that the linker is stable in for several hours. Reversible addition-fragmentation chain transfer (RAFT) polymerization was used to synthesize two various sized water-soluble block copolymer of oligoethylene glycol methylether methacylate and methyl acrylic acid (POEGMEMA(35)-b-PMAA(200) and POEGMEMA(26)-b-PMAA(90)). The platinum drug, oxoplatin, was then subsequently attached to the polymer via ester formation leading to platinum loading of 12 wt % as determined by TGA. The platinum-induced amphiphilic block copolymers that consequently led to the formation of micelles of sizes 150 and 20 nm in an aqueous environment with the longer PMAA block forming larger micelles. The small micelles were in addition cross-linked using 1,8-diaminooctane to further stabilize their structure. The targeting ability of folate conjugated polymeric micelles was investigated against two types of tumor cell lines: A549 (-FR) and OVCAR-3 (+FR). The cell line growth inhibitory efficacy of material synthesized was evaluated by using SRB method. The results revealed that folate conjugated micelles showed higher activity in FR + OVCAR-3 cells but not in FR - A549 cells. Similar results were obtained for both small and large micelles without the conjugation of folate. Comparing large and small micelles it can be observed that larger micelles are more efficient, which has been attributed to the lower stability of the smaller micelles. Micelle stabilization via cross-linking could indeed increase the toxicity of the drug carrier.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23469757     DOI: 10.1021/bm400121q

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  10 in total

Review 1.  Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives.

Authors:  Gantumur Battogtokh; Yeon Su Choi; Dong Seop Kang; Sang Jun Park; Min Suk Shim; Kang Moo Huh; Yong-Yeon Cho; Joo Young Lee; Hye Suk Lee; Han Chang Kang
Journal:  Acta Pharm Sin B       Date:  2018-05-18       Impact factor: 11.413

2.  Tumor-mesoporous silica nanoparticle interactions following intraperitoneal delivery for targeting peritoneal metastasis.

Authors:  Derek Hargrove; Brian Liang; Raana Kashfi-Sadabad; Gaurav N Joshi; Laura Gonzalez-Fajardo; Sterling Glass; Michael Jay; Andrew Salner; Xiuling Lu
Journal:  J Control Release       Date:  2020-11-07       Impact factor: 9.776

Review 3.  Folate-conjugated nanoparticles as a potent therapeutic approach in targeted cancer therapy.

Authors:  Behdokht Bahrami; Mousa Mohammadnia-Afrouzi; Peyman Bakhshaei; Yaghoub Yazdani; Ghasem Ghalamfarsa; Mehdi Yousefi; Sanam Sadreddini; Farhad Jadidi-Niaragh; Mohammad Hojjat-Farsangi
Journal:  Tumour Biol       Date:  2015-07-05

4.  Development of phenylboronic acid-functionalized nanoparticles for emodin delivery.

Authors:  Bo Wang; Limin Chen; Yingjuan Sun; Youliang Zhu; Zhaoyan Sun; Tiezhu An; Yuhua Li; Yuan Lin; Daping Fan; Qian Wang
Journal:  J Mater Chem B       Date:  2015       Impact factor: 6.331

5.  Folic Acid-Doxorubicin-Double-Functionalized-Lipid-Core Nanocapsules: Synthesis, Chemical Structure Elucidation, and Cytotoxicity Evaluation on Ovarian (OVCAR-3) and Bladder (T24) Cancer Cell Lines.

Authors:  Rodrigo Cé; Vladimir Lavayen; Gabriela Klein Couto; João Guilherme Barreto De Marchi; Barbara Zoche Pacheco; Letícia Antunes Natividade; Tiago Ost Fracari; Taiane Medeiro Ciocheta; Aline de Cristo Soares Alves; Denise Soledade Jornada; Silvia Stanisçuaski Guterres; Fabiana Seixas; Tiago Collares; Adriana Raffin Pohlmann
Journal:  Pharm Res       Date:  2021-02-19       Impact factor: 4.200

6.  Using an RNAi Signature Assay To Guide the Design of Three-Drug-Conjugated Nanoparticles with Validated Mechanisms, In Vivo Efficacy, and Low Toxicity.

Authors:  Jonathan C Barnes; Peter M Bruno; Hung V-T Nguyen; Longyan Liao; Jenny Liu; Michael T Hemann; Jeremiah A Johnson
Journal:  J Am Chem Soc       Date:  2016-09-14       Impact factor: 15.419

Review 7.  Targeting Nanomedicines to Prostate Cancer: Evaluation of Specificity of Ligands to Two Different Receptors In Vivo.

Authors:  Amanda K Pearce; Adrian V Fuchs; Nicholas L Fletcher; Kristofer J Thurecht
Journal:  Pharm Res       Date:  2016-05-25       Impact factor: 4.200

8.  Macromolecular Pt(IV) Prodrugs from Poly(organo)phosphazenes.

Authors:  Helena Henke; Kushtrim Kryeziu; Jelena Banfić; Sarah Theiner; Wilfried Körner; Oliver Brüggemann; Walter Berger; Bernhard K Keppler; Petra Heffeter; Ian Teasdale
Journal:  Macromol Biosci       Date:  2016-05-12       Impact factor: 4.979

9.  Systematic investigation of functional ligands for colloidal stable upconversion nanoparticles.

Authors:  Hien T T Duong; Yinghui Chen; Sherif Abdulkader Tawfik; Shihui Wen; Maryam Parviz; Olga Shimoni; Dayong Jin
Journal:  RSC Adv       Date:  2018-01-26       Impact factor: 3.361

10.  Lipiodol nanoemulsions stabilized with polyglycerol-polycaprolactone block copolymers for theranostic applications.

Authors:  Trang Huyen Le Kim; Hwiseok Jun; Jin Ho Kim; Keunchil Park; Jee Seon Kim; Yoon Sung Nam
Journal:  Biomater Res       Date:  2017-10-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.